WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002026834) 32624 A NOVEL HUMAN UDP-GLUCURONOSYL AND GLYCOSYL TRANSFERASE FAMILY MEMBER AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/026834    International Application No.:    PCT/US2001/029963
Publication Date: 04.04.2002 International Filing Date: 25.09.2001
Chapter 2 Demand Filed:    22.04.2002    
IPC:
C12N 9/10 (2006.01), C12Q 1/68 (2006.01)
Applicants: MILLENNIUM PHARMACEUTICALS INC. [US/US]; 75 Sidney Street, Cambridge, MA 02139-4169 (US) (For All Designated States Except US).
LEIBY, Kevin, R. [US/US]; (US) (For US Only)
Inventors: LEIBY, Kevin, R.; (US)
Priority Data:
60/235,044 25.09.2000 US
Title (EN) 32624 A NOVEL HUMAN UDP-GLUCURONOSYL AND GLYCOSYL TRANSFERASE FAMILY MEMBER AND USES THEREOF
(FR) ELEMENT DE LA FAMILLE DE UDP-GLUCURONOSYLE ET GLYCOSYLE TRANSFERASE HUMAINE, 32624, ET UTILISATIONS CORRESPONDANTES
Abstract: front page image
(EN)The invention provides isolated nucleic acids molecules, designated 32624 nucleic acid molecules, which encode novel UDP-glucuronosyl and plycosyl transferase members. The invention also provides antisense nucleic acids molecules, recombinant expression vectors containing 32624 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 32624 gene has been introduced or disrupted. The invention still further provides isolated 32624 proteins, fusion proteins, antigenic peptides and anti-32624 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
(FR)L'invention concerne des molécules d'acides nucléiques isolées, appelées molécules d'acides nucléiques 32624, qui codent des nouveaux éléments de UDP-glucuronosyle et glycosyle transférase. Cette invention a également des molécules d'acides nucléiques antisens, des vecteurs d'expression recombinante renfermant des molécules d'acides nucléiques 32624, des cellules hôtes dans lesquelles on a introduit des vecteurs d'expression, et des animaux transgéniques non humains chez lesquels on a introduit ou interrompu un gène 32624. Ladite invention concerne, en outre, des protéines 32624 isolées, des protéines hybrides, des peptides antigéniques et des anticorps anti-32624, ainsi que des méthodes diagnostiques utilisant ces compositions.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)